Bio Usawa Deal History & Licensing Activity
Bio Usawa is a life sciences. Over the past three years, Bio Usawa has been involved in 1 licensing and acquisition transaction, with a primary focus on Other (2 deals).
Deals (12mo)
1
Active Trials
0
Top Modality
Other
Focus Area
Metabolic
Bio Usawa Recent Deal Activity
Licensing, acquisition, and partnership transactions involving Bio Usawa in the past 12 months.
| Asset | Partner | Modality | Phase | Type | Date |
|---|---|---|---|---|---|
| DynaShield™ | Nanoly Bioscience | Other | Unknown | license | Feb 2026 |
Bio Usawa Pipeline Focus
Therapeutic areas and modalities where Bio Usawa is most active based on deal history and clinical trial data.
Bio Usawa Strategic Signals
Key indicators of Bio Usawa's licensing and acquisition strategy, including patent expirations, pipeline gaps, and strategic priorities.
Strategic Profile
Acquisition Appetite
See How Your Asset Matches Bio Usawa's Portfolio
Use our deal calculator to benchmark upfront payments, milestones, and royalties for Metabolic assets — powered by data from 3,500+ real biopharma transactions.
Related Intelligence
Metabolic Deal Benchmarks
Market sizing, deal terms, and competitive landscape for metabolic
Other Benchmarks
Upfront, milestone, and royalty benchmarks for other deals
Deal Pulse
Track the latest biopharma licensing and acquisition deals across all therapeutic areas
All Company Profiles
Browse 850+ biotech and pharma company profiles with deal history and pipeline data
2026 Deal Benchmarks Report
Industry-wide analysis of deal terms, trends, and market dynamics
About Bio Usawa Licensing & Deal Activity
Bio Usawa is a life sciences company that has been actively engaged in licensing transactions across the biopharma landscape. With 1 deal over the past three years, Bio Usawa ranks among the actively acquisitive companies tracked by Ambrosia Ventures.
Key therapeutic areas of focus for Bio Usawa include Metabolic (2 deals and trials). In terms of modality, Bio Usawa has shown particular interest in other.
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for Bio Usawa and 850+ other biopharma companies. Use our deal calculator to benchmark your asset against Bio Usawa's historical deal terms, or explore all company profiles to find the best partner match for your pipeline.